Akira Karasawa

This inventor holds 33 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kirin Co., Limited, Roussel Uclaf. Active years: 1985-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Karasawa. Retrieved from https://idiyas.com/inventor/akira-karasawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 90.9

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 6.8

ph-index = 12

Forward Citations = 302(Granted Patents)

Location History:

Huntingdon Valley, PA (US) (1991 - 1996)
Shizuoka-ken, JP (1996)
Shizouka, JP (2001)
Sunto-gun, JP (1997 - 2008)
Shizuoka, JP (1985 - 2010)

Company Filing History:

30 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

2 out of 272

Kyowa Hakko Kirin Co., Limited

University of Pittsburgh

patents

where one patent can have more than one assignee

Years Active: 1985-2010

Loading Chart...

Areas of Expertise:

Xanthine Derivatives

Tricyclic Compounds

Adenosine Uptake Inhibitors

Quinazoline Derivatives

Bladder Treatments

Benign Prostatic Hyperplasia

Piperidinyl Compounds

Condensed Purine Derivatives

Physiologically Active Substances

Peptide Derivatives

1,4-Dihydropyridine Derivatives

Thromboxane A.sub.2 Antagonists

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7727994 - Methods of treating patients suffering from movement disorders (2010-06-01),

2. 7727993 - [object Object] (2010-06-01),

3. 7354949 - Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia (2008-04-08),

4. 7276532 - Remedies for vesical hyperactivity (2007-10-02),

5. 7122173 - Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia (2006-10-17),

6. 6211227 - Tricyclic compounds (2001-04-03),

7. 5948784 - Quinazoline derivatives (1999-09-07),

8. 5866574 - Pancreatitis remedy (1999-02-02),

9. 5726325 - Tricyclic compounds (1998-03-10),

10. 5658917 - Isoquinolines having adenosine uptake inhibitor activity (1997-08-19),

11. 5648353 - Quinazolines and phthalazines having adenosine uptake inhibitor activity (1997-07-15),

12. 5624926 - Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors (1997-04-29),

13. 5605900 - Benzotriazines having adenosine uptake inhibitor activity (1997-02-25),

14. 5525607 - Xanthine compounds (1996-06-11),

15. 5342841 - Xanthine derivatives (1994-08-30),

Title: Inventor Akira Karasawa - Pioneering Innovations in Shizuoka

Introduction: Akira Karasawa is a visionary inventor based in Shizuoka, Japan, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Akira Karasawa holds several patents in the areas of robotics, artificial intelligence, and sustainable energy solutions, showcasing her commitment to creating a more advanced and sustainable future.

Career Highlights: With a career spanning over two decades, Akira Karasawa has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout her career, Akira Karasawa has collaborated with top engineers, scientists, and researchers to bring her innovative ideas to life, leading to successful partnerships and groundbreaking inventions.

Conclusion: Akira Karasawa's passion for innovation and dedication to pushing the boundaries of technology have solidified her reputation as a pioneering inventor in Shizuoka and beyond.

Profile summary based on public USPTO records.